Comprehensive Study Notes: Microbial Pathogenesis, Immunity, and Antimicrobial Agents

Ch. 20 – Antimicrobial Drugs

Mechanisms of Action of Antimicrobial Agents

Antimicrobial agents target specific structures or functions in microorganisms to inhibit their growth or kill them. Understanding their mechanisms is crucial for effective treatment and combating resistance.

• Antimicrobial Peptides (AMPs): AMPs disrupt microbial cell membranes, leading to cell lysis. They are part of the innate immune system and act by forming pores or disrupting membrane integrity.

• Tetracycline: Inhibits protein synthesis by binding to the 30S ribosomal subunit, preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This action is bacteriostatic.

• Griseofulvin: An antifungal agent that interferes with microtubule function, inhibiting mitosis in fungal cells. It is used to treat dermatophyte infections.

Treatment of Protozoan and Helminthic Diseases: These diseases are treated with specific agents such as metronidazole (for protozoa) and mebendazole or praziquantel (for helminths). Treatment targets unique aspects of parasite biology, such as metabolic pathways or neuromuscular function.

Disk-Diffusion Tests and Results

The disk-diffusion (Kirby-Bauer) test assesses the susceptibility of bacteria to antibiotics. Disks impregnated with antibiotics are placed on an agar plate inoculated with the test organism. Zones of inhibition indicate susceptibility.

• Large zone: Organism is sensitive to the antibiotic.

• Small or no zone: Organism is resistant.

Ch. 19 – Disorders Associated with the Immune System

Hypersensitivity and Immunological Reactions

• Anaphylaxis: A severe, rapid allergic reaction involving IgE antibodies and mast cell degranulation, leading to histamine release and systemic effects.

• Agglutination Reaction: Antibodies cause particulate antigens to clump together, used in blood typing and pathogen detection.

• Complement Fixation Reaction: Detects the presence of specific antibodies by their ability to fix complement in the presence of antigen.

• Immunofluorescence Reaction: Uses fluorescent-labeled antibodies to detect antigens in tissues or cells under a fluorescence microscope.

• Neutralization Reaction: Antibodies neutralize toxins or viruses, preventing their biological activity.

• Precipitation Reaction: Soluble antigens and antibodies form insoluble complexes, visible as a precipitate.

Ch. 18 & 17 – Practical Applications of Immunology & Adaptive Immunity

Types of Vaccines and Examples

• Live Attenuated Vaccines: Contain weakened pathogens (e.g., MMR vaccine).

• Inactivated (Killed) Vaccines: Contain killed pathogens (e.g., Salk polio vaccine).

• Subunit Vaccines: Contain only antigenic parts (e.g., acellular pertussis vaccine).

• Toxoid Vaccines: Contain inactivated toxins (e.g., tetanus toxoid).

• Conjugate Vaccines: Link polysaccharide antigens to proteins (e.g., Hib vaccine).

• mRNA Vaccines: Contain messenger RNA encoding antigen (e.g., COVID-19 vaccines).

Antibody Titers and Disease Development

• Antibody Titer: The concentration of antibodies in serum, measured by serial dilution. High titers indicate recent or ongoing infection or successful vaccination.

Types of Immunity

• Innate Immunity: Non-specific, present at birth (e.g., skin, phagocytes).

• Naturally Acquired Active Immunity: Resulting from infection; body produces its own antibodies.

• Naturally Acquired Passive Immunity: Antibodies transferred from mother to fetus or infant (e.g., via placenta or breast milk).

• Artificially Acquired Active Immunity: Resulting from vaccination.

• Artificially Acquired Passive Immunity: Injection of antibodies (e.g., antitoxin).

Antibody Structure

• Regions: Each antibody has variable (V) and constant (C) regions. The variable region binds antigen; the constant region determines the antibody class.

• Epitope: The specific part of an antigen recognized by an antibody.

MHC Class I and II

• MHC Class I: Present on all nucleated cells; present endogenous antigens to CD8+ T cells.

• MHC Class II: Present on antigen-presenting cells; present exogenous antigens to CD4+ T cells.

Ch. 16 – Innate Immunity: Nonspecific Defenses of the Host

Components of Innate Immunity

• Physical Barriers: Skin, mucous membranes.

• Ciliary Escalator: Cilia in the respiratory tract move mucus and trapped microbes upward toward the throat.

• Cellular Immunity: Involves phagocytic cells (e.g., neutrophils, macrophages) and natural killer (NK) cells.

• Toll-Like Receptors (TLRs): Recognize pathogen-associated molecular patterns (PAMPs) and activate immune responses.

• Complement System: A group of serum proteins that enhance immune responses by opsonization, inflammation, and cell lysis.

• Immunity Against Helminths: Eosinophils and IgE-mediated responses are important for defense against parasitic worms.

Ch. 15 – Microbial Mechanisms of Pathogenicity

Pathogenicity and Virulence Factors

• ID50 (Infectious Dose 50): The number of microbes required to cause infection in 50% of a population.

• LD50 (Lethal Dose 50): The number of microbes or toxin required to kill 50% of a population.

• Endotoxins: Lipopolysaccharides (LPS) from Gram-negative bacteria; cause fever and shock; released upon cell death.

• Exotoxins: Proteins secreted by bacteria; highly toxic; specific effects (e.g., neurotoxins, enterotoxins).

• Siderophores: Molecules secreted by bacteria to scavenge iron from the host.

• Superantigens: Toxins that cause excessive immune activation by non-specifically activating T cells.

• Mechanisms of Entry: Pathogens enter via mucous membranes, skin, or parenteral routes (e.g., cuts, injections).

Ch. 14 – Principles of Disease and Epidemiology

Transmission and Epidemiological Terms

• Biological Transmission: Pathogen develops or multiplies in the vector (e.g., malaria in mosquitoes).

• Mechanical Transmission: Passive transfer by vector (e.g., flies carrying pathogens on feet).

• Healthcare-Associated (Nosocomial) Infections: Infections acquired in healthcare settings.

• Endemic: Constantly present in a population.

• Epidemic: Sudden increase in cases above normal.

• Pandemic: Worldwide epidemic.

• Sporadic: Occurs occasionally.

• Incidence: Number of new cases in a given time period.

• Prevalence: Total number of cases at a given time.

• Herd Immunity: Resistance of a population due to immunity of most members.

Types and Stages of Infection

• Acute Infection: Rapid onset, short duration.

• Inapparent (Subclinical) Infection: No noticeable symptoms.

• Chronic Infection: Develops slowly, persists over time.

• Primary Infection: Initial infection by a pathogen.

• Secondary Infection: Subsequent infection by another pathogen.

• Stages: Incubation, prodromal, illness, decline, convalescence.

• Predisposing Factors: Factors that increase susceptibility (e.g., age, genetics, immunosuppression).

Ch. 13 – Viruses, Viroids, and Prions

Viral Life Cycles and Replication

• Latency: Virus remains dormant in host cells, can reactivate later (e.g., herpesviruses).

• Lytic Cycle: Virus replicates and lyses host cell, releasing new virions.

• Steps in DNA Virus Replication: Attachment, penetration, uncoating, biosynthesis, maturation, release.

Ch. 12 – The Eukaryotes: Fungi, Algae, Protozoa, and Helminths

Characteristics and Diseases

• Helminths: Multicellular parasitic worms (e.g., nematodes, trematodes, cestodes); complex life cycles.

• Fungi: Eukaryotic, cell walls of chitin, reproduce by spores.

• Lichens: Symbiotic association between a fungus and a photosynthetic partner (alga or cyanobacterium).

Spread and Infection of Selected Diseases

• Rocky Mountain Spotted Fever: Caused by Rickettsia rickettsii, transmitted by ticks.

• Lyme Disease: Caused by Borrelia burgdorferi, transmitted by Ixodes ticks.

• Malaria: Caused by Plasmodium species, transmitted by Anopheles mosquitoes.

• Pneumocystis: Caused by Pneumocystis jirovecii, an opportunistic fungal infection in immunocompromised hosts.

Ch. 11 – The Prokaryotes: Domains Bacteria and Archaea

Characteristics of Selected Bacteria

Genus/Species	Key Characteristics
Escherichia	Gram-negative rods, facultative anaerobes, normal gut flora, some pathogenic strains (e.g., E. coli O157:H7)
Staphylococcus	Gram-positive cocci, clusters, catalase-positive, includes S. aureus (can cause skin infections, MRSA)
Bordetella	Gram-negative coccobacilli, causes pertussis (whooping cough)
Treponema	Spirochete, causes syphilis (T. pallidum)
Streptococcus	Gram-positive cocci, chains, catalase-negative, includes S. pyogenes (strep throat)
Salmonella	Gram-negative rods, causes typhoid fever and gastroenteritis
Shigella	Gram-negative rods, causes bacillary dysentery
Enterobacter	Gram-negative rods, opportunistic pathogens
Campylobacter	Gram-negative curved rods, causes gastroenteritis
Borrelia burgdorferi	Spirochete, causes Lyme disease
Mycoplasma hominis	Lacks cell wall, causes urogenital infections
Mycobacterium leprae	Acid-fast bacillus, causes leprosy
Clostridium botulinum	Gram-positive, spore-forming anaerobe, produces botulinum toxin
Listeria monocytogenes	Gram-positive rod, causes listeriosis
Yersinia	Gram-negative rods, includes Y. pestis (plague)
Serratia	Gram-negative rods, produces red pigment, opportunistic infections

Ch. 10 – Classification of Microorganisms

Taxonomy and Phylogeny

• Genus: A taxonomic category ranking above species and below family; groups species with common characteristics.

• Phylogenetic Tree: Diagram showing evolutionary relationships. Closely related organisms share a recent common ancestor and are grouped together.

Extended Answers and Comparisons

• How Do You Acquire Antibodies? Through natural infection (active immunity), maternal transfer (passive immunity), vaccination (artificial active), or injection of antibodies (artificial passive).

• Endotoxins vs. Exotoxins:

Feature	Endotoxins	Exotoxins
Chemical Nature	Lipopolysaccharide (LPS)	Protein
Source	Gram-negative bacteria	Gram-positive and some Gram-negative bacteria
Heat Stability	Stable	Unstable (usually)
Toxicity	Low	High
Effect	Fever, shock	Specific (e.g., neurotoxic, cytotoxic)

• The Complement System: A cascade of serum proteins that enhances ("complements") the ability of antibodies and phagocytic cells to clear microbes. Functions include opsonization, chemotaxis, and cell lysis.

Key Equations

• Antibody Titer Calculation:

$\text{Titer} = \frac{1}{\text{highest dilution showing a positive reaction}}$

• ID50 and LD50:

$\text{ID}_{50} = \text{Dose that infects 50\% of the population}$

$\text{LD}_{50} = \text{Dose that kills 50\% of the population}$

Additional info: Some explanations and examples have been expanded for clarity and completeness.